Taiho Obtains Taiwanese Approval For TS One For Gastric Cancer
This article was originally published in PharmAsia News
Executive Summary
Taiwan's drug regulators approved Taiho Pharmaceutical's TS One capsule for gastric cancer adjunct therapy after surgery